Molecular Therapy: Methods & Clinical Development (Sep 2023)

Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine

  • Ekramy E. Sayedahmed,
  • Marcelo Valdemir Araújo,
  • Taiana Tainá Silva-Pereira,
  • Shubhada K. Chothe,
  • Ahmed Elkashif,
  • Marwa Alhashimi,
  • Wen-Chien Wang,
  • Andrea P. Santos,
  • Meera Surendran Nair,
  • Abhinay Gontu,
  • Ruth Nissly,
  • Antônio Francisco de Souza Filho,
  • Mariana Silva Tavares,
  • Marina Caçador Ayupe,
  • Caio Loureiro Salgado,
  • Érika Donizetti de Oliveira Candido,
  • Danielle Bruna Leal Oliveira,
  • Edison Luiz Durigon,
  • Marcos Bryan Heinemann,
  • Denise Morais da Fonseca,
  • Chinnaswamy Jagannath,
  • Ana Marcia Sá Guimarães,
  • Suresh V. Kuchipudi,
  • Suresh K. Mittal

Journal volume & issue
Vol. 30
pp. 194 – 207

Abstract

Read online

Because of continual generation of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is critical to design the next generation of vaccines to combat the threat posed by SARS-CoV-2 variants. We developed human adenovirus (HAd) vector-based vaccines (HAd-Spike/C5 and HAd-Spike) that express the whole Spike (S) protein of SARS-CoV-2 with or without autophagy-inducing peptide C5 (AIP-C5), respectively. Mice or golden Syrian hamsters immunized intranasally (i.n.) with HAd-Spike/C5 induced similar levels of S-specific humoral immune responses and significantly higher levels of S-specific cell-mediated immune (CMI) responses compared with HAd-Spike vaccinated groups. These results indicated that inclusion of AIP-C5 induced enhanced S-specific CMI responses and similar levels of virus-neutralizing titers against SARS-CoV-2 variants. To investigate the protection efficacy, golden Syrian hamsters immunized i.n. either with HAd-Spike/C5 or HAd-Spike were challenged with SARS-CoV-2. The lungs and nasal turbinates were collected 3, 5, 7, and 14 days post challenge. Significant reductions in morbidity, virus titers, and lung histopathological scores were observed in immunized groups compared with the mock- or empty vector-inoculated groups. Overall, slightly better protection was seen in the HAd-Spike/C5 group compared with the HAd-Spike group.

Keywords